CG Oncology所有資訊

CG Oncology | 8-K：重大事件

05/24 08:16 (美東)

CG Oncology | 4：持股變動聲明-高管 Patterson Joshua F.

05/16 19:02 (美東)

CG Oncology | 3：首次持股聲明-高管 Patterson Joshua F.

05/16 17:14 (美東)

CG Oncology | 8-K：CG Oncology公佈2024年第一季度財務業績並提供業務最新情況

05/09 08:12 (美東)

CG Oncology | 10-Q：季度報表

05/09 06:12 (美東)

CG Oncology | 8-K：重大事件

05/03 16:37 (美東)

CG Oncology | SC 13G/A：超過5%持股股東披露文件(修正)-Xiangmin Cui(8.2%),Decheng Capital Global Life Sciences Fund IV, L.P.(7.4%)等

04/09 19:16 (美東)

CG Oncology | 4/A：持股變動聲明(修正)-股東 Decheng Capital Global Life Sciences Fund IV, L.P.

04/09 19:11 (美東)

CG Oncology | 10-K：年度報表

03/26 06:09 (美東)

CG Oncology | SC 13G：超過5%持股股東披露文件-Kissei Pharmaceutical Co., Ltd.(5.3%)

03/14 19:30 (美東)

CG Oncology | 8-K：重大事件

02/16 16:23 (美東)

CG Oncology | SC 13G：超過5%持股股東披露文件-TCG Crossover GP I, LLC(5.4%),TCG Crossover Fund I, L.P.(5.4%)等

02/09 16:39 (美東)

CG Oncology | SC 13G：超過5%持股股東披露文件-Xiangmin Cui(7.6%),Decheng Capital Global Life Sciences Fund IV, L.P.(6.9%)等

02/08 17:21 (美東)

CG Oncology | SC 13G：超過5%持股股東披露文件-Patrick G. Enright(7.0%),Juliet Tammenoms Bakker(7.0%)等

02/05 16:44 (美東)

CG Oncology | SC 13G：超過5%持股股東披露文件-James Tananbaum (“Tananbaum”)(5.7%),Foresite Capital Fund VI, L.P. (“FCF VI”)(3.2%)等

02/05 15:19 (美東)

CG Oncology | 4：持股變動聲明-高管 Kasturi Vijay

01/31 16:34 (美東)

CG Oncology | 4：持股變動聲明-高管 Roche Corleen M.

01/31 16:33 (美東)

CG Oncology | 4：持股變動聲明-董事 Song Hong Fang

01/31 16:33 (美東)

CG Oncology | 4：持股變動聲明-股東 Decheng Capital Global Life Sciences Fund IV, L.P.

01/31 16:20 (美東)

CG Oncology | 8-K：重大事件

01/30 07:12 (美東)